<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03405532</url>
  </required_header>
  <id_info>
    <org_study_id>SahlgrenskaUHMT02</org_study_id>
    <nct_id>NCT03405532</nct_id>
  </id_info>
  <brief_title>Kidney Function in Diabetics During CPB (Cardio Pulmonary Bypass)</brief_title>
  <acronym>DM-ECC</acronym>
  <official_title>The Effect of the CPB on Kidney Blood Flow, Function and Oxygen Uptake During Open Heart Surgery in Patients With Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Filtration of urine in the kidney requires sufficient oxygen supply. The filtration of urine&#xD;
      is greater in patents with diabetes. Our theory is that the diabetic kidney has a higher&#xD;
      oxygen demand than the non diabetic kidney thereby making the diabetic kidney more sensitive&#xD;
      to decreased oxygen delivery following reduced blood flow. With a catheter inserted into the&#xD;
      kidney vein we will monitor the blood flow and oxygen saturation before and during CPB, in&#xD;
      patient with diabetes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 11, 2018</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Renal O2 extraction</measure>
    <time_frame>2 years</time_frame>
    <description>Renal O2 extraction measured by sampling blood from a catheter inserted into the kidney vein.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GFR</measure>
    <time_frame>2 years</time_frame>
    <description>GFR (Glomerular filtration rate), measured with CrEDTA- and PAH- clearance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal blood flow</measure>
    <time_frame>2 years</time_frame>
    <description>Change in renal blood flow measured by sampling blood from a catheter inserted into the kidney vein</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Diabetes Mellitus, Kidney, CPB</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>DM-ECC</intervention_name>
    <description>Diabetes mellitus CPB</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diabetes mellitus undergoing surgery requiring CBP.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with diabetes mellitus&#xD;
&#xD;
          -  Serum creatinine &lt; 150 micromol/L preoperative&#xD;
&#xD;
          -  Heart surgery requiring CPB&#xD;
&#xD;
          -  LV (left ventricle) EF &gt;40 %&#xD;
&#xD;
          -  Normal hemoglobin&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven-Erik Ricksten, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska Universitetssjukhuset</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 5, 2018</study_first_submitted>
  <study_first_submitted_qc>January 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Maria Thol√©n</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

